朝藿定B
分析標(biāo)準(zhǔn)品,HPLC≥98%
Epimedin B
CAS號：110623-73-9
分子式：C38H48O19
分子量：808.78
MDL：MFCD04039834
別名：朝藿定 B; 朝藿定B;;Epimedin?B; Epmedin B
貨號 | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20172-10mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥700.00 | 現(xiàn)貨 |
YJ-B20172-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1100.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：162-164 ℃
沸點(diǎn)：1066.1℃ at 760 mmHg
外觀：黃色粉末
溶解性：DMSO : 33.33 mg/mL (41.21 mM; Need ultrasonic)
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(39篇)
39. [IF=3.8] Jialu Shen et al."Insights into inhibitory mechanisms: Unraveling the structure-activity relationship of dietary flavonoids on gut bacterial β-glucuronidase."Journal of Functional Foods.2024 Nov;122:106510
38. [IF=2.5] Zheng Junzuo et al."Pharmacokinetics of seven major components in Aβ1-42-treated rats after oral administration of an aqueous extract of Curculiginis Rhizoma and Epimedii Folium."Journal of Natural Medicines.2024 Nov;:1-16
37. [IF=4.3] Yang Linlin et al."Spraying methyl jasmonate before harvesting can significantly increase the content of icariin in an important leaf medicinal herb, Epimedium sagittatum, by activating the expression of genes involved in flavonoid synthesis pathways."BMC
36. [IF=6.7] Xinguang Liu et al."Screening effective-component compatibility from Jinshui Chenfei formula for silicosis treatment by serum-pharmacochemistry and feedback system control."PHYTOMEDICINE.2025 Mar;138:156419
35. [IF=4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15:
34. [IF=4.9] Zheyuan Shen et al."Rapid evaluation of the quality of Epimedium with different processing degrees by E-eye and NIR spectroscopy combined with machine learning."MICROCHEMICAL JOURNAL.2024 Oct;205:111181
33. [IF=4.7] Li Liu et al."Epimedin B exerts an anti-inflammatory effect by regulating the MAPK/NF-κB/NOD-like receptor signalling pathways."FISH & SHELLFISH IMMUNOLOGY".2024 Jul;150:109657
32. [IF=5.4] Yi-min Liu et al."Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of Epimedium against liver cancer through a comprehensive investigation."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116765
31. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176:
30. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646
29. [IF=6.352] Lin Yu et al."Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis."Microbial Cell Factories.2023 Dec;22(1):1-11
28. [IF=6.208] Yu Yao et al."A Novel 3-O-rhamnoside: 2″-O-xylosyltransferase Responsible for Terminal Modification of Prenylflavonol Glycosides in Epimedium pubescens Maxim.."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(24):16050
27. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380
26. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747
25. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231
24. [IF=4.996] Yuan Jie et al."Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology."Scientific Reports.2022 Jul;12(1):1-24
23. [IF=5.988] Li Pin et al."Epimedium koreanum Nakai–Induced Liver Injury—A Mechanistic Study Using Untargeted Metabolomics."Frontiers in Pharmacology.2022 Jul;0:2288
22. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556
21. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80
20. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137
19. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309
18. Zhou, Yan-dan, et al. "Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway." Biomedicine & Pharmacotherapy 109 (2019): 2309-2317.https:##doi.org/10.1016/j.biopha.2018.11.108
17. 吳嫣艷,任會旭,馮友龍,張莉,張妤琳.安神補(bǔ)腦膠囊HPLC指紋圖譜與3種成分含量測定方法研究[J].廣東藥科大學(xué)學(xué)報(bào),2020,36(06):778-783.
16. 黃楷迪,劉敬霞,牛陽,馬學(xué)琴,張婷,卜凡淑,任慧,郭盛,錢大瑋,段金廒.回藥扎里奴思方UPLC指紋圖譜結(jié)合多成分含量測定的質(zhì)控方法研究[J].南京中醫(yī)藥大學(xué)學(xué)報(bào),2021,37(01):77-82.
15. 許婷,黃萌萌,李瑞云,楊茹,劉麗芳,陳彥.多基原淫羊藿不同部位質(zhì)量評價(jià)研究[J].中草藥,2020,51(01):190-196.
14. 蘭海,劉欣妍,余玲,莫諾蘭,張燕,郭子右,吳清.大孔樹脂純化淫羊藿中朝藿定與淫羊藿苷工藝研究[J].中草藥,2020,51(17):4473-4481.
13. 楊成梓 范興 包俠萍 等. HPLC同時(shí)測定芪骨膠囊中5種成分的含量[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2015 021(016):60-63.
12. 彭靜, 馬益華, 陳彥,等. 固定化蝸牛酶同時(shí)生物轉(zhuǎn)化淫羊藿中4種黃酮苷[J]. 中成藥, 2016, 38(9):1984-1990.
11. 高霞, 陳彥, 王瑩,等. 糊精濕法制粒對淫羊藿總黃酮酶解的影響[J]. 中成藥, 2014, 36(007):1392-1397.
10. 高霞, 劉璇, 陳彥,等. 淫羊藿總黃酮的生物轉(zhuǎn)化過程分析[J]. 中國中藥雜志, 2013, 38(23):4079.
9. 劉聰燕, 高霞, 陳彥,等. 淫羊藿總黃酮在骨質(zhì)疏松大鼠體內(nèi)的藥動學(xué)行為[J]. 中成藥, 2017, 39(008):1595-1600.
8. 劉聰燕, 高霞, 黃萌萌,等. 淫羊藿總黃酮仿生酶解腸溶膠囊的制備及評價(jià)[J]. 中草藥, 2016(20).
7. 姜新剛, 賈繼明, 李葉雙. 津力達(dá)顆粒UPLC指紋圖譜[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志, 2013, 19(001):126-129.
6. 張燕. 大孔吸附樹脂分離純化淫羊藿EF5黃酮[J]. 北方藥學(xué), 2015, 000(011):11-13.
5. 李婧,王英哲,劉玉翠,景志賢,閆莉,郭俊杰,姜大成,肖井雷.地理環(huán)境因子對朝鮮淫羊藿黃酮類成分空間分布影響的探測分析[J].中國中藥雜志,2019,44(24):5368-5374.
4. 劉聰燕 高霞 陳彥 等. 仿生酶解腸溶膠囊提高淫羊藿總黃酮口服生物利用度的可行性研究[J]. 中國醫(yī)藥工業(yè)雜志 2016(9期):1158-1164.
3. 王英哲 姜大成 容路生 肖井雷 張強(qiáng) 翁麗麗.東北產(chǎn)朝鮮淫羊藿中黃酮類成分的對比分析[J].藥物分析雜志 2019 39(11):2034-2040.
2. 范興, 楊成梓, 包俠萍,等. 芪骨膠囊HPLC指紋圖譜研究[J]. 中草藥, 2014, 045(009):1257-1261.
1. 王瑩 高霞 陳彥 等. 卡波姆對淫羊藿總黃酮酶解效果的影響[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2014 20(009):1-5.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實(shí)驗(yàn)服務(wù)及論文潤色十多年，是您值得信賴的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
實(shí)驗(yàn)室代做實(shí)驗(yàn)項(xiàng)目
| |||
細(xì)胞熒光染料標(biāo)記檢測實(shí)驗(yàn)
| |||
| |||
染色質(zhì)免疫沉淀分析(CLIP)實(shí)驗(yàn)服務(wù)
| |||
| |||
|
